Background: Hepatitis C virus (HCV) infection is a significant cause of morbidity and mortality in end stage renal disease (ESRD) patients on hemodialysis (HD). Routine HCV viremia screening is recommended in those patients but it is not applied.
Introduction
Worldwide, 130-170 million persons are living with chronic hepatitis C virus (HCV) infection [1] , which, if left untreated, can result in cirrhosis and liver cancer. Egypt has the largest burden of HCV infection in the world, with a 14% prevalence of chronic HCV infection among persons aged 15-59 years [2] . HCV transmission in Egypt is associated primarily with inadequate infection control during medical and dental care procedures [3, 4] .
Hepatitis C virus (HCV) infection is a severe problem in maintenance hemodialysis patients whom are at particular high risk for blood-borne infections because of prolonged vascular access and potential for exposure to contaminated equipment [5] The prevalence of HCV infection among dialysis patients is generally much higher than healthy blood donors and general population. Studies held in dialysis centers from different countries revealed that prevalence ranges form 1-84.6% and there is a particular concern because HCV chronic infection causes significant morbidity and mortality among patients undergoing hemodialysis (HD) [6] . In Egypt the prevalence of HCV infection was variable ranging from 49% to 64% [7] .
Risk factors for HCV infection in dialysis patients include number of blood transfusions, duration of HD, and mode of dialysis, prevalence of HCV infection in the dialysis unit, previous organ transplantation, intravenous drug use, male gender, older age, and nosocomial transmission of HCV in HD units [8] [9] [10] [11] .
The spread of HCV infection in HD units is mainly due to nosocomial transmission between patients [12, 13] . In order to control the diffusion of HCV in hemodialysis units some authors recommended using a separate section to dialyze HCV+ patients [14] , especially in hemodialysis units with a high HCV prevalence or in which there is no fulltime infection control personnel dedicated to the infected patients during the hemodialysis sessions, could have a greater risk of sero-conversion [15] .
Prompt detection of de novo HCV among dialysis patients is required to limit nosocomial spread of HCV. Enzyme immunoassay (EIA) provided excellent accuracy, with 0-0.23% false-negative rates. Thus, EIA-3 is an effective screening tool for HCV infection in patients with ESRD [16] . But, similar to other viral infections, the window period in HCV infection is still a major problem. During the window period, specific antibodies are not detectable, but the virus is present in the blood. For this reason, anti-HCV tests are unable to identify the subjects in this early stage of infection. The stage prior to seroconversion may last up to 2 months in immunocompetent subjects and as long as 6-12 months in immunodeficient patients [17] . Consequently, implementation of high sensitivity techniques for screening of HCV viremia in HD units should be applied.
The aim of this study was to evaluate the rate of seroconversion in anti HCV Ab negative and viremia negative patients after 12 month HD by PCR and to assess the role of isolation on the rate of seroconversion in those patients.
Materials and Methods

Study population
The prospective study included 100 end stage Renal disease (ESRD) Egyptian patients who underwent regular HD, fifty of them (Group A) recruited from a University hospital HD unit and the other fifty patients (Group B) were selected from a private HD unit. These two HD units are using the same infection control guidelines. Patient selection criteria was to be seronegative on three successive testing and to be confirmed in our lab as HCV RNA negative, those who proved HCV Ab negative but HCV RNA positive were excluded from the study. This study was approved by the local research ethics committee of National Research Center and a written informed consent was obtained from all participants in this study.
Virological testing
The detection of HCV antibodies (Ab) was determined every three month of the study by third generation ELISA (Dia Sorin, Torino, Italy) according to the manufacturer protocol. Serum RNA was extracted using Biozol reagent according to manufacturer protocol, HCV was detected using the conventional reverse transcription-polymerase chain reaction (RT-PCR) as described previously [18] .
Statistical analysis
Statistical analysis was performed using version 16 of the SPSS computer program. Data of different variables were expressed as means ± SD. Ttest was used to compare means for continuous variables and for non-normally distributed continuous variables. Comparison between distributions of categorical variables was performed using Chi-square (χ²) test. In addition, variables were described as odds ratio (OR) with 95% confidence interval (95% CI) where appropriate. The data were considered significant if p values was < 0.05 and highly significant if p < 0.01.
Results
Demographic data, clinical and laboratory investigations of the study population
The demographic data and clinical procedures for patients included in the current study were outlined as shown in Table 1 ; the laboratory investigations of the two groups of patients before and after HD are summarized in Table 2 . In brief, except gender all seroconversion risk factors were significantly higher in group A compared to group B. Notably, ALT level was significantly higher in group A before HD, and this difference was lost after HD due to elevation of its level in group B after HD.
Results of detection of HCV RNA after HD
After one year of HD, all patients were HCV Ab negative by ELISA. While HCV RNA was detected in 16% of group B patients, but none of group A http://www.mjms.mk/ patients had detectable HCV RNA Table 3 . 
Discussion
HCV chronic infection causes significant morbidity and mortality among patients undergoing hemodialysis (HD) [19] . Prompt diagnosis of HCV infection in patients on chronic hemodialysis is important not only to offer the appropriate treatment for those who require it, but also to decrease the rate of infection transmission in hemodialysis units. In patients with ESRD the prolonged window period and the risk of infection spread through hemodialysis devices are among other reasons to look for a simple, reliable diagnostic method for HCV infection even before anti-HCV Ab production, in this population of patients, as a critical step for the control of infection spread in hemodialysis units [20] . This study was conducted to assess the rate of seroconversion in HCV Ab and viremia negative HD patients using a sensitive PCR technique and to evaluate the role of isolation in HD units on the rate of seroconversion in this patient's category. Results in this study revealed a statistically significant difference in the rate of seroconversion based on ELISA results (0%) compared to that based on PCR (16%). As they were HCV RNA negative at initiation of the study, this ensures either a false negative ELISA results or they may be at the window period and both explanations are satisfactory and are concordant with previous studies who showed that the rate of HCV ab negative viremia detected by PCR in hemodialysis patients was reported to be 0-12% globally and that a false negative rate of 17.9% has been detected for HCV Ab among Egyptian hemodialysis patients [21, 22] . Consequently, the rate of seroconversion calculated based on ELISA results only is underestimated and it is highly recommended to depend on PCR in HCV surveillance in Egyptian HD units, a conclusion that matches with previously described by Schneeberger et al, [23] . Nonetheless, this criterion is not yet applicable in most HD units in Egypt.
As this study was designed to assess the role of isolation in HD units on seroconversion, the two HD units were chosen to be applying exactly the same infection control criteria, but isolation of HCV patients was applied in only one of them. Notably, the seroconversion was detected in patients of GB only but not in patients of GA, in other words seroconversion was not seen in patients from the HD unit applying the isolation strategy but was evident in patients from the HD unit not using the isolation policy.
To ensure that the seroconversion was due to experiencing the isolation in the HD unit, we studied all other risk factors which may be responsible for it. As the infection control criteria were exactly the same, we compared seroconversion risk factors in the two groups including age, duration of HD, shifting between dialysis units, antibilharzial treatment, and presence of Diabetes Mellitus (DM). Strikingly, all of them were significantly higher in GA than GB patients; nonetheless GA patients maintained 0% seroconversion versus 16% seroconversion in GB, bringing a strong evidence of the isolation role in seroconversion in this study.
The role of isolation in control of HCV spreading in HD units is controversial, Although some studies found that nosocomial spread of HCV declined when HCV-infected patients were treated in dedicated HD units [24, 25] , other investigators could control nosocomial spread of HCV by strict application of hygienic precautions without isolation of HCV-infected subjects or machine segregation [26, 27] . Similarly in Egypt, results are controversial, while Shebeb et al., [28] showed that strict adherence to universal precautions was more effective than anti HCV seropositive patients isolation in limiting the spread of HCV infection among hemodialysis patients, two recent studies [29, 30] confirmed that strict isolation of HCV+ patients in combination with implementation of universal prevention measures can limit the spread of HCV infection in HD patients. Notably all these studies evaluated seroconvertion by third generation ELISA only. In this study we emphasize the role of isolation of HCV positive patients on control of HCV infection spread in HD units in Egypt.
In conclusion, surveillance of HCV in HD units should be done using PCR technique not only ELISA. Isolation of HCV positive patients in HD units protects from dissemination of HCV infection.
